losartan has been researched along with natriuretic peptide, brain in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (13.04) | 18.2507 |
| 2000's | 25 (54.35) | 29.6817 |
| 2010's | 15 (32.61) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukui, T; Horio, T; Kohno, M; Kurihara, N; Takeda, T; Yasunari, K; Yokokawa, K; Yoshiyama, M | 1 |
| Leskinen, H; Ruskoaho, H; Vuolteenaho, O | 1 |
| Magga, J; Marttila, M; Ruskoaho, H; Vuolteenaho, O | 1 |
| Gardner, DG; Liang, F | 1 |
| Kähönen, M; Kalliovalkama, J; Magga, J; Pörsti, I; Romppanen, H; Ruskoaho, H; Tolvanen, JP; Vuolteenaho, O | 1 |
| Hirose, N; Kinoshita, M; Koga, A; Matsuki, H; Miki, K; Ogawa, M; Ogimoto, M; Saku, K | 1 |
| Kinoshita, M; Mabuchi, N; Maeda, K; Ohnishi, M; Tsutamoto, T; Tsutsui, T | 1 |
| Brown, MJ; Cockcroft, JR | 1 |
| Fukuda, N; Onose, Y; Sakabe, K; Shinohara, H; Soeki, T; Tamura, Y | 1 |
| Ambrosi, P; Andréjak, M; Gayet, JL | 1 |
| Fan, M; Jolma, P; Kähönen, M; Kalliovalkama, J; Kööbi, P; Pörsti, I; Ruskoaho, H; Rysä, J; Tikkanen, I; Vuolteenaho, O; Ylitalo, P | 1 |
| deChâtel, R; Földes, G; Ilves, M; Lakó-Futó, Z; Leskinen, H; Ruskoaho, H; Sármán, B; Skoumal, R; Szokodi, I; Tokola, H; Tóth, M; Vuolteenaho, O | 1 |
| Charles, CJ; Espiner, EA; Frampton, CM; Nicholls, MG; Rademaker, MT; Richards, AM | 1 |
| Anzai, T; Hashimoto, K; Himeno, H; Imai, K; Kawana, M; Kitakaze, M; Koretsune, Y; Maruyama, S; Masaoka, Y; Matsubara, H; Matsuoka, T; Miyao, Y; Miyatake, K; Miyauchi, T; Nakamura, Y; Nomura, F; Okamoto, H; Ozono, K; Sekiya, M; Shinohara, H; Shintani, U; Shiraki, T; Takaoka, H; Tsutamoto, T; Yasumura, Y; Yokoya, K; Yokoyama, H | 1 |
| Bang, LE; Devereux, RB; Fossum, E; Hall, C; Hildebrandt, P; Ibsen, H; Olsen, MH; Rokkedal, J; Tuxen, C; Wachtell, K | 1 |
| Bang, LE; Devereux, RB; Fossum, E; Hall, C; Hildebrandt, PR; Ibsen, H; Olsen, MH; Rokkedal, J; Tuxen, C; Wachtell, K | 1 |
| Asai, T; Fujita, H; Kanmatsuse, K; Kushiro, T | 1 |
| Chan, KL; Dore, A; Ducharme, A; Houde, C; Juneau, M; Khairy, P; Marcotte, F; Mercier, LA | 1 |
| Gottsäter, A; Ohlin, AK; Ohlin, H; Tingberg, E | 1 |
| Araujo, AQ; Arteaga, E; Buck, PC; Ianni, BM; Mady, C; Rabello, R | 1 |
| Hirata, A; Igarashi, M; Kadomoto, Y; Tominaga, M | 1 |
| Dahlöf, B; Devereux, RB; Hall, C; Hildebrandt, PR; Ibsen, H; Kjeldsen, SE; Nielsen, OW; Olsen, MH; Wachtell, K; Wergeland, R | 1 |
| Dahlöf, B; Devereux, RB | 1 |
| Tinel, H | 1 |
| Barba, J; Castellano, JM; Díez, J; González, A; López, B | 1 |
| Anand, I; Dickstein, K; Manhenke, C; Ng, L; Orn, S; Squire, IB | 1 |
| Chen, HJ; Chen, JZ; Ni, YL; Yu, M; Zhang, WF; Zhao, LL | 1 |
| Jia, M; Li, L; Liu, RY; Lu, PQ; Zhang, JY; Zhao, XY | 1 |
| Djøseland, O; Hall, C; Karlberg, BE; Klinge, R | 1 |
| Azuma, K; Dejima, T; Ishigami, T; Kanaoka, T; Maeda, A; Masuda, S; Mitsuhashi, H; Ohnishi, T; Ohsawa, M; Okano, Y; Ozawa, M; Tamura, K; Tokita, Y; Toya, Y; Tsurumi-Ikeya, Y; Umemura, S; Wakui, H; Yamauchi, J; Yanagi, M | 1 |
| Ichihara, A; Itoh, H; Kinouchi, K; Kurauchi-Mito, A; Sakoda, M | 1 |
| Kang, BY; Khan, JA; Mehta, JL; Ryu, S; Seung, KB; Shekhar, R | 1 |
| Inoue, A; Mitsutake, R; Miura, S; Saku, K; Shiga, Y; Uehara, Y | 1 |
| Damman, K; Hemmelder, M; Laverman, GD; Navis, G; Slagman, MC; Vogt, L; Waanders, F | 1 |
| Akaba, K; Endo, S; Fukui, A; Gomi, H; Hamaguchi, A; Hanaoka, K; Hara, Y; Hasegawa, T; Hayakawa, H; Hayashi, F; Hikida, M; Hirano, K; Horiguchi, M; Hosoya, M; Hosoya, T; Ichida, K; Ikeda, M; Imai, T; Ishii, T; Ishikawa, H; Ishikawa, M; Kameda, C; Kanai, T; Kasai, T; Kawamura, T; Kobayashi, A; Kobayashi, H; Kurashige, M; Kuriyama, S; Kusama, Y; Maezawa, H; Maezawa, Y; Maruyama, Y; Matsuda, H; Matsuo, N; Matsuo, T; Miura, Y; Miyajima, M; Miyakawa, M; Miyazaki, Y; Mizuguchi, M; Morita, T; Nakao, M; Nokano, H; Ogura, M; Ohkido, I; Ohno, I; Ohtsuka, Y; Okada, K; Okamoto, H; Okonogi, H; Saikawa, H; Saito, H; Sekiguchi, C; Soejima, M; Suetsugu, Y; Sugano, N; Suzuki, T; Takahashi, H; Takahashi, Y; Takamizawa, S; Takane, K; Takazoe, K; Tanaka, H; Tanaka, S; Terawaki, H; Tokudome, G; Tomonari, H; Toyoshima, R; Tsuboi, N; Udagawa, T; Ueda, H; Ueda, Y; Uetake, M; Unemura, S; Utsunomiya, M; Utsunomiya, Y; Yamada, T; Yamada, Y; Yamaguchi, Y; Yamamoto, H; Yokoo, T; Yokoyama, K; Yonezawa, H; Yoshida, H; Yoshida, M; Yoshizawa, T | 1 |
| Inou, T; Kobayashi, K; Kubara, I; Meno, H; Nakamura, Y; Ota, T; Shiga, Y; Tanaka, M; Tsuchiya, Y | 2 |
| Eguchi, K; Fukutomi, M; Hoshide, S; Kabutoya, T; Kario, K; Watanabe, T | 1 |
| Aggarwal, A; Alexiou, A; Karapanagiotidis, S; Kinghorn, A; Lee, G; Pedagogos, E; Raspudic, M; Yapanis, A; Zentner, D | 1 |
| Lin, J; Lin, L; Peng, F; Tang, H | 1 |
| Adem, A; Al Haj, M; Benedict, S; Frampton, CM; Kazzam, E; Lewis, LK; Nagelkerke, N; Nicholls, MG; Nyberg, F; Yandle, TG; Yasin, J | 1 |
| Aizawa, T; Amino, M; Deguchi, Y; Ikari, Y; Kanda, S; Tanabe, T; Yoshioka, K | 1 |
| Barretto, AC; Brancalhão, EC; Cardoso, JN; Ochiai, ME; Oliveira, MT; Puig, RS; Vieira, KR | 1 |
| Fujiwara, H; Furukawa, Y; Kita, Y; Matsuda, M; Miyazaki, S; Sato, Y; Sawa, T; Takatsu, Y; Tanaka, M | 1 |
| Bacchiani, G; Beggiato, M; Cardinale, D; Casiraghi, M; Cipolla, CM; Civelli, M; Colombo, A; Colombo, N; Lamantia, G; Meroni, CA; Salvatici, M; Sandri, MT; Spaggiari, L; Tedeschi, I; Veglia, F; Venturino, M | 1 |
| Fang, P; Geng, J; Li, Z; Liu, Q; Lu, D; Shan, Q; Wang, K; Wang, S; Wang, Y; Zhang, Q | 1 |
2 review(s) available for losartan and natriuretic peptide, brain
| Article | Year |
|---|---|
[The best of clinical pharmacology in 2002].
Topics: Anticholesteremic Agents; Antihypertensive Agents; Azetidines; Cardiovascular Diseases; Ezetimibe; Hormone Replacement Therapy; Humans; Hydrazones; Hypercholesterolemia; Losartan; Myocardial Infarction; Natriuretic Agents; Natriuretic Peptide, Brain; Neovascularization, Physiologic; Nicorandil; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Vasodilator Agents | 2003 |
Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atenolol; Atrial Fibrillation; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Cardiovascular Agents; Cohort Studies; Drug Utilization; Endothelium, Vascular; Follow-Up Studies; Heart Atria; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Models, Biological; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Precursors; Randomized Controlled Trials as Topic; Research Design; Risk; Risk Factors; Stroke; Thrombosis; Treatment Outcome | 2007 |
20 trial(s) available for losartan and natriuretic peptide, brain
| Article | Year |
|---|---|
Combined inhibition of angiotensin II and endothelin suppresses the brain natriuretic peptide response to developing heart failure.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Bosentan; Cardiac Output; Cardiac Output, Low; Cardiac Pacing, Artificial; Cyclic GMP; Endothelin Receptor Antagonists; Endothelin-1; Female; Infusions, Parenteral; Losartan; Natriuretic Peptide, Brain; Renin; Sheep; Sulfonamides | 2004 |
Rationale for the use of combination angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker therapy in heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Drug Synergism; Drug Therapy, Combination; Exercise Tolerance; Female; Heart Failure; Heart Function Tests; Humans; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Receptors, Angiotensin; Renin; Tetrazoles; Valine; Valsartan | 2004 |
N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: a LIFE study.
Topics: Aged; Anti-Infective Agents; Atenolol; Disease-Free Survival; Female; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Peptide Fragments; Predictive Value of Tests; Proportional Hazards Models; Risk Factors; Stroke; Ultrasonography | 2004 |
Opposite effects of losartan and atenolol on natriuretic peptides in patients with hypertension and left ventricular hypertrophy: a LIFE substudy.
Topics: Aged; Atenolol; Atrial Natriuretic Factor; Blood Pressure; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Peptide Fragments | 2005 |
Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebo-controlled clinical trial.
Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Cross-Over Studies; Double-Blind Method; Echocardiography, Transesophageal; Epinephrine; Exercise; Humans; Losartan; Natriuretic Peptide, Brain; Norepinephrine; Oxygen Consumption; Peptide Fragments; Transposition of Great Vessels; Treatment Outcome; Ventricular Dysfunction, Right | 2005 |
Lipid peroxidation is not increased in heart failure patients on modern pharmacological therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Comorbidity; Delayed-Action Preparations; Dinoprost; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Lipid Peroxidation; Losartan; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Nitric Oxide Donors; Oxidative Stress; Ramipril; Stroke Volume; Ultrasonography; Ventricular Dysfunction, Left | 2006 |
Dual blockade of angiotensin II with enalapril and losartan reduces proteinuria in hypertensive patients with type 2 diabetes.
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; C-Reactive Protein; Cystatin C; Cystatins; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Proteinuria; Transforming Growth Factor beta | 2006 |
N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
Topics: Aged; Aged, 80 and over; Albumins; Antihypertensive Agents; Atenolol; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Confounding Factors, Epidemiologic; Creatinine; Endpoint Determination; Female; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Predictive Value of Tests; Proportional Hazards Models; Risk Factors; ROC Curve; Scandinavian and Nordic Countries | 2006 |
Association of increased plasma cardiotrophin-1 with inappropriate left ventricular mass in essential hypertension.
Topics: Adult; Aged; Angiotensin II Type 2 Receptor Blockers; Antihypertensive Agents; Atenolol; Biomarkers; Blood Pressure; Cytokines; Diastole; Female; Heart Ventricles; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Systole; Ultrasonography | 2007 |
Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Heart Ventricles; Humans; Losartan; Magnetic Resonance Imaging; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Severity of Illness Index; Stroke Volume; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2007 |
Effect of losartan on ambulatory short-term blood pressure variability and cardiovascular remodeling in hypertensive patients on hemodialysis.
Topics: Adiponectin; Aged; Angiotensin II Type 1 Receptor Blockers; Ankle; Antihypertensive Agents; Biomarkers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Brachial Artery; Circadian Rhythm; Female; Glycation End Products, Advanced; Humans; Hypertension; Hypertrophy, Left Ventricular; Lipoproteins, LDL; Losartan; Male; Malondialdehyde; Middle Aged; Natriuretic Peptide, Brain; Regression Analysis; Renal Dialysis; Time Factors; Treatment Outcome; Ultrasonography; Ventricular Remodeling | 2009 |
Safety and benefits of a tablet combining losartan and hydrochlorothiazide in Japanese diabetic patients with hypertension.
Topics: Adult; Albuminuria; Aldosterone; Antihypertensive Agents; Asian People; Blood Pressure; Cross-Over Studies; Diabetes Complications; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Renin; Tablets; Treatment Outcome | 2009 |
Elevated N-terminal pro-brain natriuretic peptide levels predict an enhanced anti-hypertensive and anti-proteinuric benefit of dietary sodium restriction and diuretics, but not angiotensin receptor blockade, in proteinuric renal patients.
Topics: Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Case-Control Studies; Cross-Over Studies; Diet, Sodium-Restricted; Diuretics; Double-Blind Method; Female; Humans; Kidney Failure, Chronic; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Protein Precursors; Proteinuria; Renin-Angiotensin System; Sodium Chloride, Dietary; Young Adult | 2012 |
Antihypertensive efficacy of the losartan/hydrochlorothiazide combination and its effect on plasma B-type natriuretic peptide in hypertensive patients uncontrolled by angiotensin II type 1 receptor antagonist-based therapy: a multicentre prospective obser
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies | 2012 |
Change in high-sensitive cardiac troponin T on hypertensive treatment.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biomarkers; Blood Pressure; Calcium Channel Blockers; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Troponin T | 2013 |
Can losartan and blood pressure control peri arteriovenous fistula creation ameliorate the early associated left ventricular hypertrophic response a randomised placebo controlled trial.
Topics: Adult; Aged; Antihypertensive Agents; Arteriovenous Shunt, Surgical; Blood Pressure; Female; Hemodynamics; Humans; Hypertrophy, Left Ventricular; Linear Models; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Placebos; Ultrasonography | 2012 |
Efficacy and effect on plasma B-type natriuretic peptide concentration of losartan-hydrochlorothiazide for hypertension uncontrolled by losartan-based therapy: subanalysis of a Multicentre Prospective Observational Study.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Diuretics; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Uric Acid | 2012 |
Short-term add-on therapy with angiotensin receptor blocker for end-stage inotrope-dependent heart failure patients: B-type natriuretic peptide reduction in a randomized clinical trial.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Cardiac Output, Low; Dobutamine; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Time Factors; Treatment Outcome | 2014 |
Regression of Electrocardiographic Signs of Left Ventricular Hypertrophy by Combined Treatment With Thiazide Diuretic and Angiotensin-II Receptor Blocker.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Drug Therapy, Combination; Electrocardiography; Humans; Hydrochlorothiazide; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain | 2014 |
Prevention of Atrial Fibrillation in High-risk Patients Undergoing Lung Cancer Surgery: The PRESAGE Trial.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Incidence; Losartan; Lung Neoplasms; Male; Metoprolol; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pneumonectomy; Postoperative Complications; Prospective Studies | 2016 |
24 other study(ies) available for losartan and natriuretic peptide, brain
| Article | Year |
|---|---|
Cardiac hypertrophy and brain natriuretic peptide in experimental hypertension.
Topics: Animals; Atrial Natriuretic Factor; Biphenyl Compounds; Blood Pressure; Blood Urea Nitrogen; Cardiomegaly; Chromatography, High Pressure Liquid; Creatinine; Desoxycorticosterone; Enalapril; Heart; Hydralazine; Hypertension, Malignant; Imidazoles; Losartan; Male; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Rats; Rats, Inbred SHR; Sodium, Dietary; Tetrazoles | 1994 |
Combined inhibition of endothelin and angiotensin II receptors blocks volume load-induced cardiac hormone release.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atrial Function, Right; Atrial Natriuretic Factor; Biphenyl Compounds; Blood Volume; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Hemodynamics; Hormones; Imidazoles; Losartan; Male; Myocardium; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Peptides, Cyclic; Plasma Substitutes; Pressure; Protein Precursors; Rats; Rats, Sprague-Dawley; Sulfonamides; Tetrazoles | 1997 |
Endothelin-1 is involved in stretch-induced early activation of B-type natriuretic peptide gene expression in atrial but not in ventricular myocytes: acute effects of mixed ET(A)/ET(B) and AT1 receptor antagonists in vivo and in vitro.
Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Gene Expression Regulation; Losartan; Male; Myocardium; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Perfusion; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; RNA, Messenger; Sulfonamides; Tetrazoles | 1997 |
Autocrine/paracrine determinants of strain-activated brain natriuretic peptide gene expression in cultured cardiac myocytes.
Topics: Angiotensin II; Animals; Antibodies; Autocrine Communication; Cells, Cultured; Culture Media, Conditioned; Endothelin-1; Gene Expression Regulation; Genes, Reporter; Humans; Losartan; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Paracrine Communication; Peptides, Cyclic; Promoter Regions, Genetic; Rats; RNA, Messenger; Sprains and Strains; Transfection; Transforming Growth Factor beta; Ventricular Function | 1998 |
Differential regulation of cardiac adrenomedullin and natriuretic peptide gene expression by AT1 receptor antagonism and ACE inhibition in normotensive and hypertensive rats.
Topics: Adrenomedullin; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Enalapril; Gene Expression; Heart; Hypertension; Losartan; Male; Natriuretic Peptide, Brain; Peptides; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reference Values | 1999 |
Chronic beneficial effects of type 1 angiotensin II receptor antagonist in patients with chronic hypoxemic pulmonary diseases.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Natriuretic Factor; Female; Humans; Losartan; Lung Diseases, Obstructive; Male; Middle Aged; Natriuretic Peptide, Brain | 2002 |
[Comparative effects of losartan and amlodipine on activities of sympathetic nerve, renin-angiotensin-aldosterone system and brain natriuretic peptide in the elderly hypertensive patients].
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Heart Rate; Humans; Hypertension; Losartan; Natriuretic Peptide, Brain; Renin-Angiotensin System; Sympathetic Nervous System | 2002 |
Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Humans; Losartan; Natriuretic Peptide, Brain | 2002 |
Effects of angiotensin II receptor antagonists on [(123)I]metaiodobenzylguanidine myocardial imaging findings and neurohumoral factors in chronic heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Natriuretic Factor; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Creatinine; Echocardiography; Female; Heart; Heart Failure; Humans; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Potassium; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Angiotensin; Renin; Severity of Illness Index; Statistics as Topic; Stroke Volume; Tetrazoles; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
AT1 receptor blockade improves vasorelaxation in experimental renal failure.
Topics: Angiotensin Receptor Antagonists; Animals; Aorta; Atrial Natriuretic Factor; Blood Pressure; Endothelium, Vascular; Heart Ventricles; In Vitro Techniques; Losartan; Male; Mesenteric Arteries; Natriuretic Peptide, Brain; Nephrectomy; Peptidyl-Dipeptidase A; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renal Insufficiency; RNA, Messenger; Vasoconstriction; Vasodilation | 2003 |
Evidence for a functional role of angiotensin II type 2 receptor in the cardiac hypertrophic process in vivo in the rat heart.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiomyopathy, Hypertrophic; Fibroblast Growth Factor 1; Gene Expression Regulation; Genes, fos; Heart Rate; Hypertension; Imidazoles; Infusion Pumps, Implantable; Losartan; Male; Natriuretic Peptide, Brain; Proto-Oncogene Proteins c-fos; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; RNA, Messenger; Vascular Endothelial Growth Factor A | 2003 |
Different effects on inhibition of cardiac hypertrophy in spontaneously hypertensive rats by monotherapy and combination therapy of adrenergic receptor antagonists and/or the angiotensin II type 1 receptor blocker under comparable blood pressure reduction
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atenolol; Blood Pressure; Cardiomegaly; Doxazosin; Drug Therapy, Combination; Echocardiography; Heart Rate; Hypertension; Losartan; Male; Natriuretic Peptide, Brain; Rats; Rats, Inbred SHR; RNA, Messenger | 2005 |
Effect of Losartan on left ventricular diastolic function in patients with nonobstructive hypertrophic cardiomyopathy.
Topics: Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Blood Flow Velocity; Cardiomyopathy, Hypertrophic; Disease Progression; Echocardiography, Doppler; Female; Follow-Up Studies; Heart Ventricles; Humans; Losartan; Male; Middle Aged; Myocardial Contraction; Natriuretic Peptide, Brain; Peptide Fragments; Treatment Outcome; Ventricular Function, Left | 2005 |
Beneficial effects of the combination of nifedipine and losartan in hypertensive Dahl salt-sensitive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Blood Pressure; Calcium Channel Blockers; Drug Therapy, Combination; Gene Expression; Hypertension; Hypertrophy, Left Ventricular; Kidney; Losartan; Male; Natriuretic Peptide, Brain; Nifedipine; Organ Size; Rats; Rats, Inbred Dahl; RNA, Messenger; Sodium Chloride, Dietary; Transforming Growth Factor beta1 | 2007 |
Losartan reduced connexin43 expression in left ventricular myocardium of spontaneously hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Blotting, Western; Connexin 43; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Myocardium; Natriuretic Peptide, Brain; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Transcription Factor RelA | 2008 |
Effects of combination therapy with perindopril and losartan on left ventricular remodelling in patients with myocardial infarction.
Topics: Aged; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Perindopril; Prospective Studies; Treatment Outcome; Ultrasonography; Ventricular Remodeling | 2009 |
Cardiac secretion of atrial and brain natriuretic peptides in acute ischaemic heart failure in pigs: effect of angiotensin II receptor antagonism.
Topics: Acute Disease; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Biomarkers; Disease Models, Animal; Embolism; Female; Heart; Heart Failure; Losartan; Male; Microspheres; Myocardial Ischemia; Myocardium; Natriuretic Peptide, Brain; Protein Precursors; Swine | 1997 |
Curcumin reduces angiotensin II-mediated cardiomyocyte growth via LOX-1 inhibition.
Topics: Angiotensin II; Animals; Antibodies; Atrial Natriuretic Factor; Cell Enlargement; Cell Line, Transformed; Cell Proliferation; Cell Survival; Curcumin; Gene Expression; Losartan; Membrane Glycoproteins; Mice; Myocytes, Cardiac; NADPH Oxidase 2; NADPH Oxidases; Natriuretic Peptide, Brain; NF-kappa B; Oxidative Stress; Protein Subunits; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Scavenger Receptors, Class E; Signal Transduction; Transfection | 2010 |
Effect of fixed-dose losartan/hydrochlorothiazide on brain natriuretic peptide in patients with hypertension.
Topics: Aged; Blood Pressure; Body Weight; Diastole; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Natriuretic Peptide, Brain; Systole | 2012 |
Antihypertensive effect of a fixed-dose combination of losartan/hydrochlorothiazide in patients with uncontrolled hypertension: a multicenter study.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Creatinine; Drug Combinations; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Hyperuricemia; Japan; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Treatment Outcome; Uric Acid; Young Adult | 2012 |
Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of losartan and amlodipine regarding long-term blood pressure, cardiac and renal protection.
Topics: Aldosterone; Amlodipine; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiotonic Agents; Collagen; Gene Expression Regulation; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Kidney; Losartan; Male; Natriuretic Peptide, Brain; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Stroke Volume; Transforming Growth Factor beta1; Ultrasonography | 2012 |
ANP and BNP responses to dehydration in the one-humped camel and effects of blocking the renin-angiotensin system.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Atrial Natriuretic Factor; Camelus; Dehydration; Losartan; Male; Myocardium; Natriuretic Peptide, Brain; Renin-Angiotensin System | 2013 |
Effects of a combination of losartan and hydrochlorothiazide in patients with hypertension and a history of heart failure.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biomarkers; Blood Pressure; Diuretics; Drug Substitution; Drug Therapy, Combination; Female; Heart Failure; Heart Function Tests; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Patient Compliance; Treatment Outcome | 2014 |
Renal denervation significantly attenuates cardiorenal fibrosis in rats with sustained pressure overload.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biomarkers; Cardiomyopathies; Disease Models, Animal; Fibrosis; Heart Atria; Heart Ventricles; Humans; Kidney; Losartan; Myocardium; Natriuretic Peptide, Brain; Peptide Fragments; Procollagen; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Sympathectomy | 2016 |